These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2527221)

  • 1. Teicoplanin administration in patients experiencing reactions to vancomycin.
    Smith SR; Cheesbrough JS; Makris M; Davies JM
    J Antimicrob Chemother; 1989 May; 23(5):810-2. PubMed ID: 2527221
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.
    Van der Auwera P; Aoun M; Meunier F
    Antimicrob Agents Chemother; 1991 Mar; 35(3):451-7. PubMed ID: 1828134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters.
    Smith SR; Cheesbrough J; Spearing R; Davies JM
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1193-7. PubMed ID: 2529814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teicoplanin for patients allergic to vancomycin.
    Schlemmer B; Falkman H; Boudjadja A; Jacob L; Le Gall JR
    N Engl J Med; 1988 Apr; 318(17):1127-8. PubMed ID: 2965303
    [No Abstract]   [Full Text] [Related]  

  • 5. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
    Van Laethem Y; Hermans P; De Wit S; Goosens H; Clumeck N
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():81-7. PubMed ID: 2965135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teicoplanin in perspective. A critical comparison with vancomycin.
    Janknegt R
    Pharm Weekbl Sci; 1991 Aug; 13(4):153-60. PubMed ID: 1834985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the safety profile of teicoplanin.
    Davey PG; Williams AH
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():69-73. PubMed ID: 1829079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teicoplanin in the treatment of skin and soft tissue infections.
    Turpin PJ; Taylor GP; Logan MN; Wood MJ
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():117-22. PubMed ID: 2965123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin and teicoplanin: something old, something new.
    Phillips G; Golledge CL
    Med J Aust; 1992 Jan; 156(1):53-7. PubMed ID: 1531153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and tolerance of teicoplanin in postoperative infections caused by gram-positive microorganisms].
    Alberghina A; Romeo B; Pessione E; Mauri A; Enrichens F; Sciascia C; Olivero G
    Minerva Chir; 1987 Sep; 42(17):1339-45. PubMed ID: 2959879
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergic cross-reactivity of teicoplanin and vancomycin.
    McElrath MJ; Goldberg D; Neu HC
    Lancet; 1986 Jan; 1(8471):47. PubMed ID: 2867290
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.
    Kureishi A; Jewesson PJ; Rubinger M; Cole CD; Reece DE; Phillips GL; Smith JA; Chow AW
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2246-52. PubMed ID: 1839490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE-mediated reaction to vancomycin and teicoplanin after treatment with vancomycin.
    Knudsen JD; Pedersen M
    Scand J Infect Dis; 1992; 24(3):395-6. PubMed ID: 1380722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria.
    Lewis P; Garaud JJ; Parenti F
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():61-7. PubMed ID: 2965133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis.
    Svetitsky S; Leibovici L; Paul M
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4069-79. PubMed ID: 19596875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and safety of teicoplanin.
    Stille W; Sietzen W; Dieterich HA; Fell JJ
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():69-79. PubMed ID: 2965134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teicoplanin.
    Salaria M
    Indian Pediatr; 2001 Apr; 38(4):372-5. PubMed ID: 11313506
    [No Abstract]   [Full Text] [Related]  

  • 18. Teicoplanin in the treatment of infection caused by gram-positive organisms.
    Williams AH; Grüneberg RN; Webster A; Ridgway GL
    J Hosp Infect; 1986 Mar; 7 Suppl A():101-3. PubMed ID: 2871091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative efficacy and safety of teicoplanin and vancomycin.
    Cobo J; Fortún J
    J Antimicrob Chemother; 1996 Dec; 38(6):1113-4. PubMed ID: 9023665
    [No Abstract]   [Full Text] [Related]  

  • 20. Vancomycin-induced neutropenia resolves after substitution with teicoplanin.
    Sanche SE; Dust WN; Shevchuk YM
    Clin Infect Dis; 2000 Sep; 31(3):824-5. PubMed ID: 11017842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.